DNM2 and cancer: CD44, as the receptor for hyaluronic acid (HA), mediates intracellular cell signaling through its interaction with cytoskeletal proteins and is involved in cell adhesion, migration, drug resistance, and signal transmission in some drug-resistant cancer cell lines (22–25).